SCHEMBL7984965

SCHEMBL7984965

CCOc1cccc(C(=O)Nc2ncn(Cc3ccccc3)c2C(N)=O)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.57
LMNA P02545 3/20 0.49
NR1H4 Q96RI1 1/20 0.49
HTT P42858 1/20 0.49
NPC1 O15118 6/20 0.48
RAB9A P51151 6/20 0.48
POLB P06746 1/20 0.48
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
SMN1; SMN2 Q16637 5/20 0.47
MAPT P10636 4/20 0.47
KMT2A Q03164 3/20 0.47
MAPK1 P28482 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
TSHR P16473 3/20 0.47
MEN1 O00255 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984687 0.92 NR1H4 (0.52) ALDH1A1NR1H4POLBMAPTKMT2A
SCHEMBL7984937 0.91 ADORA3 (0.52) ALDH1A1LMNAHTTNPC1RAB9A
SCHEMBL7974205 0.90 NR1H4 (0.52) ALDH1A1NR1H4KMT2AMEN1
SCHEMBL7985033 0.86 NLRP3 (0.46) ALDH1A1NPC1RAB9APOLBSMN1; SMN2
SCHEMBL7975241 0.85 GAA (0.50) LMNANPC1RAB9APOLBSMN1; SMN2
SCHEMBL7985340 0.85 NTRK1 (0.51) LMNANPC1RAB9ASMN1; SMN2MAPT
SCHEMBL7974265 0.85 MCHR1 (0.47) LMNAHTTNPC1RAB9APOLB
SCHEMBL7984492 0.85 ADORA2A (0.53) ALDH1A1KDM4E
SCHEMBL7984200 0.84 SMN1; SMN2 (0.53) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL7987486 0.82 KDM4E (0.48) LMNASMN1; SMN2KMT2ATSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed